This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2017 Jun;44(6):727-728.

doi: 10.1111/1346-8138.13538. Epub 2016 Jul 27.

Critical renal adverse event induced by nivolumab therapy in a stage IV melanoma patient

Aya Tanaka¹, Kuniko Ikinaga¹, Eiji Kiyohara¹, Atsushi Tanemura¹, Mari Wataya-Kaneda¹, Ryuta Fujimura², Masayuki Mizui², Yoshitaka Isaka², Ichiro Katayama¹

Affiliations

Affiliations

¹ Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
² Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine, Osaka, Japan.

PMID: 27461931
DOI: 10.1111/1346-8138.13538

Case Reports

Critical renal adverse event induced by nivolumab therapy in a stage IV melanoma patient

Aya Tanaka et al. J Dermatol. 2017 Jun.

. 2017 Jun;44(6):727-728.

doi: 10.1111/1346-8138.13538. Epub 2016 Jul 27.

Authors

Aya Tanaka¹, Kuniko Ikinaga¹, Eiji Kiyohara¹, Atsushi Tanemura¹, Mari Wataya-Kaneda¹, Ryuta Fujimura², Masayuki Mizui², Yoshitaka Isaka², Ichiro Katayama¹

Affiliations

¹ Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
² Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine, Osaka, Japan.

PMID: 27461931
DOI: 10.1111/1346-8138.13538

No abstract available

PubMed Disclaimer

Similar articles

Acute interstitial nephritis after sequential ipilumumab - nivolumab therapy of metastatic melanoma.
Bottlaender L, Breton AL, de Laforcade L, Dijoud F, Thomas L, Dalle S. Bottlaender L, et al. J Immunother Cancer. 2017 Jul 18;5(1):57. doi: 10.1186/s40425-017-0261-2. J Immunother Cancer. 2017. PMID: 28716106 Free PMC article.
The Analysis of Renal Infiltrating Cells in Acute Tubulointerstitial Nephritis Induced by Anti-PD-1 Antibodies: A Case Report and Review of the Literature.
Tabei A, Watanabe M, Ikeuchi H, Nakasatomi M, Sakairi T, Kaneko Y, Maeshima A, Kaira K, Hirato J, Nojima Y, Hiromura K. Tabei A, et al. Intern Med. 2018 Nov 1;57(21):3135-3139. doi: 10.2169/internalmedicine.0444-17. Epub 2018 Jun 6. Intern Med. 2018. PMID: 29877267 Free PMC article. Review.
Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report.
Koda R, Watanabe H, Tsuchida M, Iino N, Suzuki K, Hasegawa G, Imai N, Narita I. Koda R, et al. BMC Nephrol. 2018 Feb 27;19(1):48. doi: 10.1186/s12882-018-0848-y. BMC Nephrol. 2018. PMID: 29486725 Free PMC article.
Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report.
Hultin S, Nahar K, Menzies AM, Long GV, Fernando SL, Atkinson V, Cebon J, Wong MG. Hultin S, et al. BMC Nephrol. 2020 Sep 7;21(1):391. doi: 10.1186/s12882-020-02044-9. BMC Nephrol. 2020. PMID: 32894101 Free PMC article.
Nivolumab in melanoma.
Specenier P. Specenier P. Expert Rev Anticancer Ther. 2016 Dec;16(12):1247-1261. doi: 10.1080/14737140.2016.1249856. Epub 2016 Nov 7. Expert Rev Anticancer Ther. 2016. PMID: 27776441 Review.

See all similar articles

Cited by

Reintroduction of nivolumab in a patient with gastric cancer after improvement of nivolumab-induced acute interstitial nephritis: a case report.
Hu Q, Hasuda H, Ueki K, Tsuchimoto A, Zaitsu Y, Tsuda Y, Hisamatsu Y, Nakashima Y, Ando K, Kimura Y, Oki E, Mori M. Hu Q, et al. Int Cancer Conf J. 2020 May 22;9(3):127-132. doi: 10.1007/s13691-020-00418-2. eCollection 2020 Jul. Int Cancer Conf J. 2020. PMID: 32582516 Free PMC article.
Biopsy-proven acute tubulointerstitial nephritis in patients treated with immune checkpoint inhibitors: a pooled analysis of case reports.
Esposito P, Bottini A, Lecini E, Cappadona F, Piaggio M, Macciò L, Genova C, Viazzi F. Esposito P, et al. Front Oncol. 2023 Oct 23;13:1221135. doi: 10.3389/fonc.2023.1221135. eCollection 2023. Front Oncol. 2023. PMID: 37936605 Free PMC article.
Commentary: Small Molecule Inhibition of PD-1 Transcription is an Effective Alternative to Antibody Blockade in Cancer Therapy.
Taylor A, Rudd CE. Taylor A, et al. J Immunol Sci. 2019 May 7;3(1):9-12. doi: 10.29245/2578-3009/2019/1.1167. J Immunol Sci. 2019. PMID: 31111120 Free PMC article. No abstract available.
Melanoma and Immune Checkpoint Inhibitors.
Furue M, Ito T, Wada N, Wada M, Kadono T, Uchi H. Furue M, et al. Curr Oncol Rep. 2018 Mar 23;20(3):29. doi: 10.1007/s11912-018-0676-z. Curr Oncol Rep. 2018. PMID: 29569208 Review.
Clinicopathological Features of Kidney Injury Related to Immune Checkpoint Inhibitors: A Systematic Review.
Xu LY, Zhao HY, Yu XJ, Wang JW, Zheng XZ, Jiang L, Wang SX, Liu G, Yang L. Xu LY, et al. J Clin Med. 2023 Feb 8;12(4):1349. doi: 10.3390/jcm12041349. J Clin Med. 2023. PMID: 36835884 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- scite Smart Citations
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal